首页> Oncotarget> Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.

导出 OA

翻译打印收藏纠错

第一作者： Dominik,Bogen

第一单位： Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.

作者： Dominik,Bogen ^[1] ; Jun S,Wei ^[2] ; David O,Azorsa ^[3] ; Pinar,Ormanoglu ^[4] ; Eugen,Buehler ^[4] ; Rajarshi,Guha ^[4] ; Jonathan M,Keller ^[4] ; Lesley A,Mathews Griner ^[4] ; Marc,Ferrer ^[4] ; Young K,Song ^[2] ; Hongling,Liao ^[2] ; Arnulfo,Mendoza ^[5] ; Berkley E,Gryder ^[2] ; Sivasish,Sindri ^[2] ; Jianbin,He ^[2] ; Xinyu,Wen ^[2] ; Shile,Zhang ^[2] ; John F,Shern ^[2] ; Marielle E,Yohe ^[2] ; Sabine,Taschner-Mandl ^[6] ; Jason M,Shohet ^[7] ; Craig J,Thomas ^[4] ; Scott E,Martin ^[4] ; Peter F,Ambros ^[6] ; Javed,Khan ^[2]

作者单位： Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria. ^[1] Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ^[2] Clinical Translational Research Division, Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA. ^[3] Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA. ^[4] Tumor and Metastasis Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ^[5] Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria. ^[6] Texas Children's Cancer Center and Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. ^[7]

关键词 AURKB MYCN barasertib high-throughput screening neuroblastoma